Alan Meds vs Corsica Health
A hundred and fifty dollars apart on the same molecule and format.
Alan Meds
Editorial
$99/mo
Three compounded lines, each carrying a published figure. Semaglutide is $99 by injection and $135 as an oral, and tirzepatide is $145 by injection. Alan Meds states the rate holds at every dose rather than rising through the escalation, which is the part of a GLP-1 bill a buyer cannot see before enrolling. No compounding pharmacy is named. Coverage is stated across 46 states.
Pick it for: Buyers comparing what a half-year actually costs
Corsica Health
Editorial
$249/mo
A plan selector where the term sets the rate: compounded semaglutide is $149 a month only inside a three-month plan billed $447 up front, and $249 on its own. Compounded tirzepatide runs $249 inside a $747 quarter and $349 month to month. Branded injections are listed separately at $1,499 as a cash purchase.
Pick it for: Buyers who want Corsica's wider service and accept the rate
Our verdict
Alan Meds publishes $99 and states it holds; Corsica Health publishes $249 with no dose behavior stated. Six months is $594 against $1,494.
What actually separates them
Alan Meds and Corsica Health state different things about published price. Everything else they publish, they publish the same way.
Corsica Health costs $150 more than Alan Meds — 152% more for the same molecule. Whether that buys anything is what the rest of this page is for.
Over twelve months that is about $1,188 at Alan Meds against $2,988 at Corsica Health — a difference of $1,800.
| Alan Meds | Corsica Health | |
|---|---|---|
| Published price | $99/mo | $249/mo |
Before you choose either
Ask both sellers what dose the monthly price buys before you compare the two figures. A price is only a price once you know what quantity it is attached to, and a seller that will not answer has told you something. Set both against every published price we hold rather than against each other alone.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.